Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Vitrakvi (Larotrectinib).
Drowsiness/reduced alertness: Vitrakvi (Larotrectinib) may cause drowsiness or dizziness, affecting your ability to drive or operate machinery. Avoid driving, operating machinery, or performing other potentially hazardous tasks until you have determined how you are affected by Vitrakvi (Larotrectinib).
Kidney function: Kidney Disease or reduced kidney function may cause Vitrakvi (Larotrectinib) to build up in the body, causing side effects. If you have kidney problems, discuss with your doctor how Vitrakvi (Larotrectinib) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Vitrakvi (Larotrectinib), and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Vitrakvi (Larotrectinib).
Liver function: Liver disease or reduced liver function may cause Vitrakvi (Larotrectinib) to build up in the body, causing side effects. If you have liver problems, discuss with your doctor how Vitrakvi (Larotrectinib) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Vitrakvi (Larotrectinib), and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Vitrakvi (Larotrectinib).
Pregnancy: Vitrakvi (Larotrectinib) should not be used during pregnancy unless the benefits outweigh the risks. Women of childbearing age who are taking Vitrakvi (Larotrectinib) and women whose partners are taking Vitrakvi (Larotrectinib), should use an effective method of birth control, such as condoms, during treatment and for at least 1 month after stopping the medication. If you become pregnant while taking Vitrakvi (Larotrectinib), contact your doctor immediately.
Breast-feeding: It is not known if Vitrakvi (Larotrectinib) passes into breast milk. If you are a breast-feeding mother and are taking Vitrakvi (Larotrectinib), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Vitrakvi (Larotrectinib) have not been established for infants less than one month of age.